Recursion Pharmaceuticals
RXRX
#3955
Rank
HK$17.40 B
Marketcap
HK$43.29
Share price
-0.89%
Change (1 day)
-28.23%
Change (1 year)

Earnings for Recursion Pharmaceuticals (RXRX)

Earnings in 2024 (TTM): -HK$3.61 Billion

According to Recursion Pharmaceuticals's latest financial reports the company's current earnings are HK$58.48 Million. a decrease over its 2023 earnings that were of -HK$2.58 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Recursion Pharmaceuticals from 2020 to 2024

Annual earnings

Year Earnings Change
2024 -HK$3.6 Billion39.51%
2023 -HK$2.58 Billion38.68%
2022 -HK$1.86 Billion30.46%
2021 -HK$1.43 Billion114.28%
2020 -HK$0.67 Billion